Table 4 Distribution of advanced ALNM (pN2-N3) stratified by total score in the training and validation cohorts
Total scorea | Training cohort | Validation cohort | ||||
|---|---|---|---|---|---|---|
Patients (n) | Advanced ALNM | Patients (n) | Advanced ALNM | |||
0 | 114 | 0 | (0.0) | 52 | 0 | (0.0) |
1 | 40 | 0 | (0.0) | 24 | 0 | (0.0) |
2 | 22 | 0 | (0.0) | 15 | 0 | (0.0) |
3 | 81 | 2 | (2.5) | 50 | 1 | (2.0) |
4 | 91 | 9 | (9.9) | 55 | 5 | (9.1) |
5 | 75 | 19 | (25.3) | 48 | 11 | (22.9) |
6 | 22 | 6 | (27.3) | 14 | 5 | (35.7) |
7 | 36 | 22 | (61.1) | 27 | 16 | (59.3) |
8 | 11 | 9 | (81.8) | 11 | 6 | (54.6) |
9 | 6 | 5 | (83.3) | 6 | 4 | (66.7) |
10 | 2 | 2 | (100) | 1 | 1 | (100) |
11 | 1 | 1 | (100) | 0 | 0 | (0.0) |
Total | 501 | 75 | (15.0) | 303 | 49 | (16.2) |